These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36444683)

  • 1. Leptin-based hexamers facilitate memory and prevent amyloid-driven AMPA receptor internalisation and neuronal degeneration.
    Doherty G; Holiday A; Malekizadeh Y; Manolescu C; Duncan S; Flewitt I; Hamilton K; MacLeod B; Ainge JA; Harvey J
    J Neurochem; 2023 Jun; 165(6):809-826. PubMed ID: 36444683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Leptin Fragment Mirrors the Cognitive Enhancing and Neuroprotective Actions of Leptin.
    Malekizadeh Y; Holiday A; Redfearn D; Ainge JA; Doherty G; Harvey J
    Cereb Cortex; 2017 Oct; 27(10):4769-4782. PubMed ID: 27600840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptin prevents aberrant targeting of tau to hippocampal synapses via PI 3 kinase driven inhibition of GSK3β.
    Hamilton K; Morrow K; Markantoni E; Harvey J
    J Neurochem; 2023 Nov; 167(4):520-537. PubMed ID: 37822142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Leptin-Based Therapeutic Strategies to Limit Synaptic Dysfunction in Alzheimer's Disease.
    Harvey J
    Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin prevents hippocampal synaptic disruption and neuronal cell death induced by amyloid β.
    Doherty GH; Beccano-Kelly D; Yan SD; Gunn-Moore FJ; Harvey J
    Neurobiol Aging; 2013 Jan; 34(1):226-37. PubMed ID: 22921154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMPA-ergic regulation of amyloid-β levels in an Alzheimer's disease mouse model.
    Hettinger JC; Lee H; Bu G; Holtzman DM; Cirrito JR
    Mol Neurodegener; 2018 May; 13(1):22. PubMed ID: 29764453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Neuronal Actions of Leptin and the Implications for Treating Alzheimer's Disease.
    Hamilton K; Harvey J
    Pharmaceuticals (Basel); 2021 Jan; 14(1):. PubMed ID: 33440796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRPV1 activation alleviates cognitive and synaptic plasticity impairments through inhibiting AMPAR endocytosis in APP23/PS45 mouse model of Alzheimer's disease.
    Du Y; Fu M; Huang Z; Tian X; Li J; Pang Y; Song W; Tian Wang Y; Dong Z
    Aging Cell; 2020 Mar; 19(3):e13113. PubMed ID: 32061032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Class I HDAC Inhibitor Rescues Synaptic Damage and Neuron Loss in APP-Transfected Cells and APP/PS1 Mice through the GRIP1/AMPA Pathway.
    Han Y; Chen L; Liu J; Chen J; Wang C; Guo Y; Yu X; Zhang C; Chu H; Ma H
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of calcineurin-mediated endocytosis and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors prevents amyloid beta oligomer-induced synaptic disruption.
    Zhao WQ; Santini F; Breese R; Ross D; Zhang XD; Stone DJ; Ferrer M; Townsend M; Wolfe AL; Seager MA; Kinney GG; Shughrue PJ; Ray WJ
    J Biol Chem; 2010 Mar; 285(10):7619-32. PubMed ID: 20032460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.
    Shemer I; Holmgren C; Min R; Fülöp L; Zilberter M; Sousa KM; Farkas T; Härtig W; Penke B; Burnashev N; Tanila H; Zilberter Y; Harkany T
    Eur J Neurosci; 2006 Apr; 23(8):2035-47. PubMed ID: 16630051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-34a deficiency in APP/PS1 mice promotes cognitive function by increasing synaptic plasticity via AMPA and NMDA receptors.
    Xu Y; Chen P; Wang X; Yao J; Zhuang S
    Neurosci Lett; 2018 Mar; 670():94-104. PubMed ID: 29378298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric modulation of AMPA receptors counteracts Tau-related excitotoxic synaptic signaling and memory deficits in stress- and Aβ-evoked hippocampal pathology.
    Monteiro-Fernandes D; Silva JM; Soares-Cunha C; Dalla C; Kokras N; Arnaud F; Billiras R; Zhuravleva V; Waites C; Bretin S; Sousa N; Sotiropoulos I
    Mol Psychiatry; 2021 Oct; 26(10):5899-5911. PubMed ID: 32467647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing the Receptor Tyrosine Kinase EphB2 Prevents Amyloid-β-induced Depletion of Cell Surface Glutamate Receptors by a Mechanism That Requires the PDZ-binding Motif of EphB2 and Neuronal Activity.
    Miyamoto T; Kim D; Knox JA; Johnson E; Mucke L
    J Biol Chem; 2016 Jan; 291(4):1719-1734. PubMed ID: 26589795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid beta-peptide Abeta(1-42) but not Abeta(1-40) attenuates synaptic AMPA receptor function.
    Parameshwaran K; Sims C; Kanju P; Vaithianathan T; Shonesy BC; Dhanasekaran M; Bahr BA; Suppiramaniam V
    Synapse; 2007 Jun; 61(6):367-74. PubMed ID: 17372971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptin attenuates the detrimental effects of β-amyloid on spatial memory and hippocampal later-phase long term potentiation in rats.
    Tong JQ; Zhang J; Hao M; Yang J; Han YF; Liu XJ; Shi H; Wu MN; Liu QS; Qi JS
    Horm Behav; 2015 Jul; 73():125-30. PubMed ID: 26135065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin and ghrelin prevent hippocampal dysfunction induced by Aβ oligomers.
    Martins I; Gomes S; Costa RO; Otvos L; Oliveira CR; Resende R; Pereira CM
    Neuroscience; 2013 Jun; 241():41-51. PubMed ID: 23506735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Food for thought: Leptin regulation of hippocampal function and its role in Alzheimer's disease.
    McGregor G; Harvey J
    Neuropharmacology; 2018 Jul; 136(Pt B):298-306. PubMed ID: 28987937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin regulation of hippocampal synaptic function in health and disease.
    Hamilton K; Harvey J
    Vitam Horm; 2021; 115():105-127. PubMed ID: 33706945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IVIG immunotherapy protects against synaptic dysfunction in Alzheimer's disease through complement anaphylatoxin C5a-mediated AMPA-CREB-C/EBP signaling pathway.
    Gong B; Pan Y; Zhao W; Knable L; Vempati P; Begum S; Ho L; Wang J; Yemul S; Barnum S; Bilski A; Gong BY; Pasinetti GM
    Mol Immunol; 2013 Dec; 56(4):619-29. PubMed ID: 23911420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.